Hall Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.47M | Buy |
25,573
+1,961
| +8% | +$113K | 0.46% | 51 |
|
|
2026
Q1 | $1.43M | Buy |
+23,612
| New | +$1.38M | 0.51% | 48 |
|
|
2025
Q1 | – | Sell |
-5,815
| Closed | -$329K | – | 94 |
|
|
2024
Q4 | $329K | Buy |
+5,815
| New | +$325K | 0.15% | 79 |
|
|
2024
Q2 | $250K | Sell |
6,015
-100
| -2% | -$4.47K | 0.12% | 88 |
|
|
2024
Q1 | $332K | Buy |
6,115
+250
| +4% | +$12.7K | 0.16% | 79 |
|
|
2023
Q4 | $301K | Hold |
5,865
| – | – | 0.18% | 78 |
|
|
2023
Q3 | $340K | Hold |
5,865
| – | – | 0.22% | 71 |
|
|
2023
Q2 | $375K | Hold |
5,865
| – | – | 0.21% | 73 |
|
|
2023
Q1 | $407K | Hold |
5,865
| – | – | 0.24% | 71 |
|
|
2022
Q4 | $422K | Hold |
5,865
| – | – | 0.25% | 71 |
|
|
2022
Q3 | $417K | Hold |
5,865
| – | – | 0.28% | 68 |
|
|
2022
Q2 | $452K | Sell |
5,865
-400
| -6% | -$30.5K | 0.3% | 64 |
|
|
2022
Q1 | $458K | Hold |
6,265
| – | – | 0.27% | 71 |
|
|
2021
Q4 | $391K | Hold |
6,265
| – | – | 0.22% | 77 |
|
|
2021
Q3 | $371K | Hold |
6,265
| – | – | 0.24% | 79 |
|
|
2021
Q2 | $419K | Buy |
+6,265
| New | +$409K | 0.27% | 74 |
|
|
2020
Q4 | $389K | Sell |
6,265
-105
| -2% | -$6.46K | 0.28% | 66 |
|
|
2020
Q3 | $384K | Sell |
6,370
-35
| -0.5% | -$2.11K | 0.3% | 62 |
|
|
2020
Q2 | $377K | Hold |
6,405
| – | – | 0.32% | 64 |
|
|
2020
Q1 | $357K | Sell |
6,405
-200
| -3% | -$12.2K | 0.36% | 59 |
|
|
2019
Q4 | $424K | Buy |
6,605
+305
| +5% | +$17.5K | 0.35% | 62 |
|
|
2019
Q3 | $319K | Hold |
6,300
| – | – | 0.28% | 68 |
|
|
2019
Q2 | $286K | Sell |
6,300
-1,325
| -17% | -$61.7K | 0.24% | 71 |
|
|
2019
Q1 | $364K | Sell |
7,625
-350
| -4% | -$17.4K | 0.32% | 65 |
|
|
2018
Q4 | $415K | Sell |
7,975
-185
| -2% | -$9.94K | 0.41% | 59 |
|
|
2018
Q3 | $507K | Sell |
8,160
-486
| -6% | -$28.8K | 0.44% | 60 |
|
|
2018
Q2 | $478K | Sell |
8,646
-3,463
| -29% | -$187K | 0.45% | 59 |
|
|
2018
Q1 | $766K | Hold |
12,109
| – | – | 0.73% | 45 |
|
|
2017
Q4 | $742K | Sell |
12,109
-500
| -4% | -$31.3K | 0.65% | 47 |
|
|
2017
Q3 | $804K | Sell |
12,609
-2,310
| -15% | -$135K | 0.74% | 43 |
|
|
2017
Q2 | $831K | Sell |
14,919
-7,834
| -34% | -$426K | 0.78% | 41 |
|
|
2017
Q1 | $1.24M | Sell |
22,753
-1,460
| -6% | -$80.1K | 1.17% | 37 |
|
|
2016
Q4 | $1.42M | Buy |
+24,213
| New | +$1.32M | 1.38% | 30 |
|
|
2015
Q3 | $1.63M | Buy |
27,465
+500
| +2% | +$31.7K | 1.93% | 19 |
|
|
2015
Q2 | $1.79M | Sell |
26,965
-670
| -2% | -$44.2K | 2.04% | 16 |
|
|
2015
Q1 | $1.78M | Buy |
27,635
+1,620
| +6% | +$101K | 1.85% | 21 |
|
|
2014
Q4 | $1.53M | Buy |
+26,015
| New | +$1.47M | 1.58% | 28 |
|
Other funds holding BMY
Hall Capital Management's BMY Position: Q2 2026 in Review
Hall Capital Management increased its Bristol-Myers Squibb (BMY) stake by 8.3% in Q2 2026, buying an estimated $113K and bringing the position to 25,573 shares worth $1.47M. The position accounts for 0.46% of the portfolio, ranked #51.
Hall Capital Management first reported a position in BMY in Q4 2014 and has held it in 37 quarters since. The position peaked at $1.79M in Q2 2015. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Hall Capital Management held 25,573 shares of Bristol-Myers Squibb worth $1.47M as of Q2 2026.
- Hall Capital Management bought 1,961 Bristol-Myers Squibb shares in Q2 2026, an estimated $113K.
- Bristol-Myers Squibb made up 0.46% of Hall Capital Management's portfolio in Q2 2026, its #51 holding.
- Hall Capital Management first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 37 quarters since.
- Hall Capital Management's Bristol-Myers Squibb position peaked at $1.79M in Q2 2015.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Hall Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.